Elizabeth Dawn Flick
About Elizabeth Dawn Flick
Elizabeth Dawn Flick is the Senior Director of Registries/Strategic Evidence Integration and Collaborations at Bristol-Myers Squibb and Celgene, with extensive experience in generating Real-World Evidence and developing Integrated Evidence Plans.
Current Position
Elizabeth Dawn Flick is the Senior Director of Registries/Strategic Evidence Integration and Collaborations at Bristol-Myers Squibb, based in the San Francisco Bay Area. In this role, she focuses on integrating strategic evidence and collaborative efforts to enhance registry data. She continues to contribute to similar responsibilities at Celgene as the Senior Director of Registries/RWD Collaborations in US Medical Affairs.
Previous Work Experience
Before her current positions, Elizabeth Dawn Flick served as the Medical Science Director, Epidemiologist, and Outcomes Researcher at Genentech from 2007 to 2014. She worked at Kaiser Permanente as a Student Researcher/Doctoral Candidate from 2005 to 2007. Earlier in her career, she spent 15 years as a Staff Pharmacist at Walgreens Pharmacy from 1996 to 2011.
Education and Expertise
Elizabeth Dawn Flick possesses an extensive educational background. She earned her Doctor of Science (ScD) in Pharmacoepidemiology from Harvard T.H. Chan School of Public Health (2003-2007). She also holds a Master of Public Health (MPH) in Epidemiology/Biostatistics from the University of California, Berkeley (2000-2002). Additionally, she acquired her Registered Pharmacist (RPh) degree from the University of the Sciences in Philadelphia (1986-1989) and her Bachelor of Arts (BA) in Biology from Lycoming College (1983-1987).
Responsibilities and Specializations
Since 2019, Elizabeth Dawn Flick has been developing Integrated Evidence Plans for Medical Affairs. Her responsibilities expanded in 2022 to encompass all therapeutic areas, including Oncology, Cardiovascular, and Immunology/Fibrosis. Following the merger of Celgene and Bristol-Myers Squibb, she gained experience in developing these plans for broader medical affairs.
Real-World Evidence Experience
Elizabeth Dawn Flick has extensive experience in generating Real-World Evidence (RWE) from various types of real-world data. She is skilled in conducting Patient Registries and developing Integrated Evidence Plans. Her expertise in generating RWE plays a crucial role in informing medical research and improving therapeutic strategies.